NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $37.04 -0.99 (-2.60%) As of 02:35 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Astrana Health Stock (NASDAQ:ASTH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Astrana Health alerts:Sign Up Key Stats Today's Range$36.78▼$38.1750-Day Range$33.55▼$40.8152-Week Range$18.08▼$51.60Volume97,080 shsAverage Volume515,284 shsMarket Capitalization$2.07 billionP/E Ratio45.20Dividend YieldN/APrice Target$49.88Consensus RatingModerate Buy Company Overview Astrana Health, Inc. is a healthcare enablement company that helps physicians and other healthcare providers deliver coordinated, value-based care. The company works with medical groups, independent physician associations and healthcare organizations to manage patient populations, improve clinical outcomes and coordinate services across primary, specialty and post-acute care settings. Astrana Health provides care-management programs, population-health analytics, technology solutions and administrative support designed to help providers manage risk-based reimbursement arrangements. Its services support Medicare Advantage, accountable care and other value-based care models, with an emphasis on preventive care, chronic-condition management, utilization management and reducing avoidable hospital and emergency-room use. The company was founded in 1994 and was formerly known as Apollo Medical Holdings, Inc. It adopted the Astrana Health name in 2023 as part of a broader effort to present its healthcare enablement platform under a unified brand. The company primarily serves healthcare providers and patients in the United States, with operations and affiliated networks concentrated in markets including California, Nevada and Texas. Astrana Health is led by Chief Executive Officer Brandon Sim.AI Generated. May Contain Errors. Read More Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks85th Percentile Overall ScoreASTH MarketRank™: 4.229559748425 of 5 starsAstrana Health scored higher than 85% of companies evaluated by MarketBeat, and ranked 74th out of 870 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on no strong buy ratings, 8 buy ratings, 2 hold ratings, and no sell ratings.Upside PotentialAstrana Health has a consensus price target of $49.88, representing about 33.2% upside from its current price of $37.44.Amount of Analyst CoverageAstrana Health has only been the subject of 4 research reports in the past 90 days.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth41.91% Earnings GrowthEarnings for Astrana Health are expected to grow by 41.91% in the coming year, from $1.36 to $1.93 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 45.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 38.85.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 45.59, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.94.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 2.66. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted6.95% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 5.8.Change versus previous monthShort interest in Astrana Health has recently decreased by 5.68%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. News and Social Media2.3 / 5News Sentiment0.60 News SentimentAstrana Health has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Astrana Health this week, compared to 4 articles on an average week. Company Ownership1.3 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by Insiders20.30% of the stock of Astrana Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ASTH Stock News HeadlinesAstrana Health (NASDAQ:ASTH) and Agilon Health (NYSE:AGL) Head to Head ComparisonOctober 16 at 2:15 AM | americanbankingnews.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 15 at 10:00 AM | prnewswire.comMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up Amazon and Netflix under $3 per share in 2005. Now the chief investment strategist at The Oxford Club has identified three AI stocks he believes could be the most profitable investments of the next decade.October 16 at 1:00 AM | The Oxford Club (Ad)INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTHOctober 13 at 5:08 PM | globenewswire.comIs Astrana Health (ASTH) Undervalued Following Its Verda Healthcare Partnership?October 12, 2026 | finance.yahoo.comAstrana Health's Unit Agrees Partnership With Verda Healthcare in Arizona and TexasOctober 12, 2026 | marketscreener.comMAstrana Health (ASTH) Stock Could Look Fully Priced On New Multi State PartnershipOctober 12, 2026 | finance.yahoo.comVerda Healthcare partners with AstranaCare units to expand care options in Arizona and TexasOctober 12, 2026 | seekingalpha.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $24.81 at the beginning of 2026. Since then, ASTH shares have increased by 50.9% and is now trading at $37.4380. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) posted its earnings results on Thursday, August, 6th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.34 by $0.46. Astrana Health's revenue was up 48.5% compared to the same quarter last year. Read the conference call transcript. Who are Astrana Health's major shareholders? Top institutional shareholders of Astrana Health include NorthCrest Asset Manangement LLC (0.29%), Insight Wealth Strategies LLC (0.25%), State of Alaska Department of Revenue (0.03%) and Farther Finance Advisors LLC. How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/06/2026Today10/16/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ASTH's financial health is in the Yellow zone, according to TradeSmith. ASTH has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.astranahealth.com Phone626-282-0288Fax818-839-5190Employees3,000Year Founded1985Price Target and Rating Average Price Target for Astrana Health$49.88 High Price Target$65.00 Low Price Target$37.00 Potential Upside/Downside+34.1%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)$0.82 Trailing P/E Ratio45.20 Forward P/E Ratio27.34 P/E GrowthN/ANet Income$22.49 million Net Margins1.05% Pretax Margin1.56% Return on Equity10.30% Return on Assets3.67% Debt Debt-to-Equity Ratio1.05 Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$3.18 billion Price / Sales0.65 Cash Flow$2.77 per share Price / Cash Flow13.41 Book Value$14.09 per share Price / Book2.64Miscellaneous Outstanding Shares55,740,000Free Float44,422,000Market Cap$2.07 billion OptionableOptionable Beta1.03 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:ASTH) was last updated on 10/16/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredThe oil check Munger called his best dealCharlie Munger's $1,000 oil investment in 1962 later paid about $70,000 a year, totaling roughly $1 million ov...The Oxford Club | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredBezos… DOOMED?A single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
